UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056058
Receipt number R000064056
Scientific Title Mechanism of worsening post-dinner blood sugar due to lunch skipping: An exploratory study using serum component analysis
Date of disclosure of the study information 2024/11/06
Last modified on 2024/11/05 16:14:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Mechanism of worsening post-dinner blood sugar due to lunch skipping: An exploratory study using serum component analysis

Acronym

Mechanism of worsening post-dinner blood sugar due to lunch skipping: An exploratory study using serum component analysis

Scientific Title

Mechanism of worsening post-dinner blood sugar due to lunch skipping: An exploratory study using serum component analysis

Scientific Title:Acronym

Mechanism of worsening post-dinner blood sugar due to lunch skipping: An exploratory study using serum component analysis

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It has been reported that skipping breakfast worsens blood sugar levels after lunch compared to eating breakfast, and we confirmed that skipping lunch also worsens blood sugar levels after dinner.
Furthermore, although hormonal changes related to blood sugar regulation and increases in free fatty acids have been observed in skipping breakfast, no studies have been conducted to analyze serum metabolites other than free fatty acids. It is thought that the serum metabolites of skipped lunch are chronotrophically different from the serum metabolites of skipped breakfast, and the search for this is thought to be novel.
Based on the above, in this study, we conduct an exploratory clinical study to comprehensively analyze serum metabolites, with the aim of getting closer to elucidating the mechanism of post-dinner blood sugar deterioration in patients who skip lunch.

Basic objectives2

Others

Basic objectives -Others

Examine how specific dietary habits affect blood glucose variability

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relative concentration of each molecule in plasma obtained by metabolomics/lipidomics analysis

Key secondary outcomes

Blood sugar level, plasma insulin, GLP-1 concentration, glucagon concentration


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom

Interventions/Control_1

Before the intervention starts, anthropometric, body composition, self-administered questionnaire are performed. This study protocol consists of two days control intervention-one week washout-two days test intervention. Each intervention sets the mealtime at 6-7 am (breakfast),0-1 pm (lunch), 6-7 pm (dinner). Blood is collected before the dinner at the second day of each intervention.

Interventions/Control_2

Control intervention and test intervention are transposed. Other intervention protocols are the same as the above protocol.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Men and women over 18 years of age with a BMI of 18.5 or more and less than 25 kg/m2 and no history of diabetes.

Key exclusion criteria

1)Pregnant women
2)Smoking
3)Skipping meals
4)Food allergies
5)Those who the research director judges to be inappropriate for research participation

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Shimba

Organization

University of Shizuoka

Division name

School of Food and Nutritional Sciences

Zip code

422-8526

Address

52-1 Yada, Suruga-ku, Shizuoka

TEL

054-264-5561

Email

shokuji@u-shizuoka-ken.ac.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Shimba

Organization

University of Shizuoka

Division name

School of Food and Nutritional Sciences

Zip code

422-8526

Address

52-1 Yada, Suruga-ku, Shizuoka

TEL

054-264-5561

Homepage URL


Email

shokuji@u-shizuoka-ken.ac.jp


Sponsor or person

Institute

University of Shizuoka

Institute

Department

Personal name



Funding Source

Organization

Urakami Foundation for Food and Food Culture Promotion

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Shizuoka

Address

52-1 Yada, Suruga-ku, Shizuoka

Tel

054-264-5103

Email

tyous10@u-shizuoka-ken.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 17 Day

Date of IRB

2024 Year 07 Month 12 Day

Anticipated trial start date

2024 Year 11 Month 06 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 05 Day

Last modified on

2024 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064056